Distalmotion has announced a partnership with Proximie, a health technology platform, to globally extend the capabilities of its Dexter robotic surgery system.
The collaboration will provide customers of Distalmotion with access to Proximie’s healthcare platform, which is designed to offer telepresence, content management and data-driven insights.
By integrating Dexter with Proximie’s advanced healthcare platform, surgeons can now collaborate regardless of their location. This is aimed at improving patient outcomes and increasing operating room (OR) productivity.
Distalmotion CEO Greg Roche said: 鈥淥ur collaboration with Proximie represents a stride forward in our mission to empower robotic surgery by providing more hospitals, surgeons and patients access to robotic excellence.
鈥淏y integrating Proximie’s platform, we are creating an ecosystem that enables greater support and innovation, elevating the standard of care.鈥�
The combined strengths of Distalmotion鈥檚 Dexter and Proximie systems will facilitate a seamless exchange of knowledge and experiences among surgeons.
US Tariffs are shifting - will you react or anticipate?
Don鈥檛 let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataAdditionally, it will enable information sharing between surgeons and Distalmotion.
Proximie founder and CEO Nadine Hachach-Haram said: 鈥淲e are delighted to announce our partnership with Distalmotion, as we collaborate to train more surgeons to use the Dexter system 鈥� thus improving patient outcomes and surgical productivity.
鈥淭he partnership is another step in our journey of digitising global ORs, enhancing patient care and providing the tools to improve the quality of surgery globally.
鈥淲e are hugely excited about the potential impact of this partnership and look forward to working with Distalmotion as we provide a valuable solution to increase accessibility to advanced robotic surgeries.鈥�
In 2022, Distalmotion raised $90m (Sfr76.59m) in a funding round led by Revival Healthcare Capital to accelerate the commercialisation of its Dexter surgical robot across the world.
